Explore more publications!
East Timor Technology Press
Got News to Share?

East Timor Technology Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on East Timor Technology Press.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 17, 2025

ODYSIGHT.AI APPOINTS EILAM SAGI AS CHIEF BUSINESS OFFICER (CBO)
November 17, 2025

ODYSIGHT.AI APPOINTS EILAM SAGI AS CHIEF BUSINESS OFFICER (CBO)

Indeterminate GlobeNewswire
Scope Technologies Corp. Achieves CyberSecure Canada Level 2 Certification, Advancing Its Leadership in Quantum-Resilient Security and Compliance
November 17, 2025

Scope Technologies Corp. Achieves CyberSecure Canada Level 2 Certification, Advancing Its Leadership in Quantum-Resilient Security and Compliance

Indeterminate GlobeNewswire
Reelables Secures $10.4M in Series A Funding to Advance Active Smart Label Technology
November 17, 2025

Reelables Secures $10.4M in Series A Funding to Advance Active Smart Label Technology

Indeterminate GlobeNewswire
Halda Therapeutics Announces Acquisition by Johnson & Johnson
November 17, 2025

Halda Therapeutics Announces Acquisition by Johnson & Johnson

Indeterminate GlobeNewswire
Datavault AI Reports 3Q-25 Highlights and Corporate Update
November 17, 2025

Datavault AI Reports 3Q-25 Highlights and Corporate Update

Indeterminate GlobeNewswire
Four Points Technology Achieves CMMC 2.0 Level 2 Certification
November 17, 2025

Four Points Technology Achieves CMMC 2.0 Level 2 Certification

Indeterminate GlobeNewswire
Ashvattha Therapeutics to Showcase Topline Phase 2 Data and Recent FDA Alignment at Upcoming Investor and Ophthalmology Meetings
November 17, 2025

Ashvattha Therapeutics to Showcase Topline Phase 2 Data and Recent FDA Alignment at Upcoming Investor and Ophthalmology Meetings

Indeterminate GlobeNewswire
Rackspace Technology Appoints Lata Varghese and Phani Kishore Burre to Senior Leadership Roles Driving Cloud and AI Transformation
November 17, 2025

Rackspace Technology Appoints Lata Varghese and Phani Kishore Burre to Senior Leadership Roles Driving Cloud and AI Transformation

Indeterminate GlobeNewswire
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
November 17, 2025

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Indeterminate GlobeNewswire
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 17, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Industry-first SDV Maturity Framework brings clarity and urgency to auto industry
November 17, 2025

Industry-first SDV Maturity Framework brings clarity and urgency to auto industry

Indeterminate GlobeNewswire
Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases
November 17, 2025

Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases

Indeterminate GlobeNewswire
Hummink raises $20 million to bring micronic precision printing to advanced manufacturing
November 17, 2025

Hummink raises $20 million to bring micronic precision printing to advanced manufacturing

Indeterminate GlobeNewswire
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
November 17, 2025

Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit

Indeterminate GlobeNewswire
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
November 17, 2025

Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference

Indeterminate GlobeNewswire
Acumen Pharmaceuticals Announces First Participant Dosed in Phase 2 Open-Label Extension Study of Sabirnetug in People with Early Alzheimer’s Disease
November 17, 2025

Acumen Pharmaceuticals Announces First Participant Dosed in Phase 2 Open-Label Extension Study of Sabirnetug in People with Early Alzheimer’s Disease

Indeterminate GlobeNewswire
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
November 17, 2025

Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

Indeterminate GlobeNewswire
Nuvini Appoints AI Industry Leader Phoebe Wang to Board of Directors
November 17, 2025

Nuvini Appoints AI Industry Leader Phoebe Wang to Board of Directors

Indeterminate GlobeNewswire
Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025
November 17, 2025

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Indeterminate GlobeNewswire
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5
November 17, 2025

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions